🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Our study now Nature Metabolism. Analysis and expansion of machine learning approaches to automate the interpretation of isotope tracing data for assessing metabolic flux. Congrats Shiyu 🎉. rdcu.be/dX4Rp

I have been an oncologist for 20 years. This means I have cared for patients pre and post ACA. When I tell you that we can NEVER - go back- please believe it come from a place of wanting all people of all ethnicities, races, socioecomics and geography to have access to the care

A gynecologic cancer diagnosis affects not just patients, but also their loved ones. OCRA offers support and resources: bit.ly/4fAU1fd. #GynCSM #NationalFamilyCaregiversMonth

I am happy to share that I have accepted an Assistant Professor Position #newPI at the Magee-Womens Research Institute Magee-Womens Research Institute & Foundation , University of Pittsburgh University of Pittsburgh . Mukherjee lab will open in January 2025.

Great selection of Spatial Proteomics as method of the year by Nature Methods!! Check out our perspective with Yuval Bussi on what we have achieved and where we are heading on the analysis of this data: rdcu.be/d2GrC

Wishing peace, strength and hope this holiday season to our community, who we stand with every step of the way. (Artwork by OCRA's “Express Yourself” program participants Cindy Janus, Jennifer Orlick, Rachel Hampton, Charlene Gregory, Danette Toledo & Tina Bembry) #GynCSM

We participated in a study led by Honami Naora Ph.D. from MD Anderson characterizing the role of B-cells in early ovarian cancer metastasis UChicago Obstetrics and Gynecology Department @gyncancer UChicago Medicine UChicagoCancerCenter

In Nature Communications, we describe a comprehensive cell atlas of healthy human fallopian tubes during the menstrual cycle and menopause using single-cell RNA and ATAC sequencing. Melanie Weigert sarah olivia ackroyd UChicagoCancerCenter Mengjie Chen UChicago Obstetrics and Gynecology Department nature.com/articles/s4146…

Another day of Ovarcoming together 🩵 . #WeOvarcome #BoardMembers

Congratulations to Yinu Wang and Jane Frederick for completing this fascinating story on the traits of #ovarian cancer stem cells. Thank you Lurie Cancer Center NM Obstetrics and Gynecology @NCICancerBio advanced.onlinelibrary.wiley.com/doi/epdf/10.10…

Pelvic ultrasound when well done and read using O-RADS 2022 has high specificity and sensitivity. See our latest paper.

Poster on spatial transcription of uterine cancer presented by Katie Kurnit and Sanaa Nakad Borrego at #AACR25 UChicago Obstetrics and Gynecology Department

Online now! Simultaneous publication with an #AACR25 poster: Navitoclax, a Bcl-2/xL inhibitor, and YM155, a Survivin Inhibitor, in Combination with Carboplatin, Effectively Inhibit Ovarian Cancer Tumor Growth: doi.org/10.1158/1535-7… AACR

Very proud of our ovarian cancer team at University of Chicago

Congratulations to Matthias Mann, Max Planck Institute of Biochemistry in Munich, Martinsried Matthias Mann Lab on election to the National Academy of Sciences!

Sridevi Challa presented a poster on metabolic regulation of PARP inhibitor response in ovarian cancer cells #AACR25

Our ovarian cancer laboratory contributed to this exciting study.

Sometimes it takes a step back—or up—to see the full picture. Take a look at UChicago from a new perspective.

New publication led by Dr. Kenny from our lab Lengyel Lab, now in Molecular Cancer Therapeutics: Dual inhibition of Bcl-2/xL (navitoclax) and survivin (YM155), combined with carboplatin, reduces ALDH^hi cell populations and tumor burden in HGSOC models. Read: aacrjournals.org/mct/article-ab…

We received the cover for our recent publication in Clinical Cancer Research. This multi-institutional study offers the first systematic proteogenomic analysis of synchronous endometrial and ovarian cancers (SEOC). Read: bit.ly/4kVgq9L Lengyel Lab Melanie Weigert Matthias Mann Lab